| abstract |
The present invention is a marker for predicting the risk of lung cancer recurrence in lung cancer patients comprising at least six polynucleotides selected from the group consisting of 18 polynucleotides listed in Table 1, wherein the markers are CALB1, MMP7, SLC1A7, GSTA2, CCL19 And markers comprising six polynucleotides consisting of IFI44, kits, microarrays and methods for predicting lung cancer recurrence risk in lung cancer patients. |